Role of Complement Systems in IVIG Mediated Attenuation of Cognitive Deterioration in Alzheimer’s Disease

E-ISSN： 1875-5828|11|7|637-644

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.11, Iss.7, 2014-09, pp. : 637-644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognitive deterioration in Alzheimer’s disease: is the early course predictive of the later stages?

By Capitani E. Cazzaniga R. Francescani A. Spinnler H.

Neurological Sciences, Vol. 25, Iss. 4, 2004-10 ,pp. : 198-204

Springer Publishing Company

Access to resources Recommend Favorite

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)

Current Alzheimer Research, Vol. 11, Iss. 7, 2014-09 ,pp. : 623-625

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M. Venu R. Somashekhar R.

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite

Rapid Improvement of Canine Cognitive Dysfunction with Immunotherapy designed for Alzheimer’s Disease

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-06 ,pp. : 482-493

Bentham Science Publishers

Access to resources Recommend Favorite